Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|October 27, 2022
Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus ErythematosusPatricia Richter, Anca Cardoneanu, Ciprian Rezus, et al.
Life (Basel, Switzerland)|October 23, 2021
Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same BackgroundElena Rezuș, Luana Andreea Macovei, Alexandra Maria Burlui, et al.
Medicina (Kaunas, Lithuania)|January 25, 2025
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future DirectionsIoan Teodor Dragoi, Ciprian Rezus, Alexandra Maria Burlui, et al.
International Journal of Molecular Sciences|February 13, 2026
Pathogenic and Clinical Relevance of Serum IL-17A and TNF-α in Systemic Lupus ErythematosusPatricia Richter, Luana Andreea Macovei, Ciprian Rezus, et al.
Metabolites|July 29, 2023
Lifestyle Patterns in Patients with Type 2 DiabetesAndreea Gherasim, Andrei C Oprescu, Ana Maria Gal, et al.
Experimental and Therapeutic Medicine|May 14, 2021
Characteristics of the intestinal microbiome in ankylosing spondylitisAnca Cardoneanu, Sebastian Cozma, Ciprian Rezus, et al.
Biomedicines|February 25, 2022
Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?Anca Cardoneanu, Alexandra Maria Burlui, Luana Andreea Macovei, et al.
Journal of Clinical Medicine|July 15, 2026
IL-6 in Systemic Lupus Erythematosus: At the Intersection of Disease Activity and Cardiovascular RiskPatricia Richter, Ciprian Rezus, Cristina Andreea Adam, et al.
Experimental and Therapeutic Medicine|February 28, 2020
A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational studyElena Rezus, Alexandra Maria Burlui, Bogdan Gafton, et al.
Pageof 3